CAPTRUST FINANCIAL ADVISORS - ORAMED PHARMACEUTICALS INC ownership

ORAMED PHARMACEUTICALS INC's ticker is ORMP and the CUSIP is 68403P203. A total of 119 filers reported holding ORAMED PHARMACEUTICALS INC in Q4 2021. The put-call ratio across all filers is 0.60 and the average weighting 0.0%.

Quarter-by-quarter ownership
CAPTRUST FINANCIAL ADVISORS ownership history of ORAMED PHARMACEUTICALS INC
ValueSharesWeighting
Q1 2022$1,000
-50.0%
61
-59.9%
0.00%
Q4 2021$2,000
-33.3%
152
+25.6%
0.00%
Q3 2021$3,000
+200.0%
121
+142.0%
0.00%
Q2 2021$1,000500.00%
Other shareholders
ORAMED PHARMACEUTICALS INC shareholders Q4 2021
NameSharesValueWeighting ↓
MORGAN JESS S & CO INC 576,317$1,504,0001.50%
Phoenix Holdings Ltd. 197,763$483,0000.02%
Frontier Wealth Management LLC 71,900$188,0000.02%
GSA CAPITAL PARTNERS LLP 19,659$51,0000.01%
Rossmore Private Capital 15,061$39,0000.01%
ETF MANAGERS GROUP, LLC 98,486$255,0000.01%
Virtu Financial LLC 10,450$27,0000.01%
BOURGEON CAPITAL MANAGEMENT LLC 5,627$15,0000.01%
Sterling Investment Advisors, Ltd. 3,150$8,0000.00%
Qube Research & Technologies Ltd 75,395$197,0000.00%
View complete list of ORAMED PHARMACEUTICALS INC shareholders